NXT Q1 2026 Earnings EPS Surprises 1316 Above Estimates Fennec Pharmaceuticals Q1 2026 Earnings EPS Surprise Beats Estimates Amidst PreRevenue Stage PRTA Q1 2026 Earnings Biotech Surprises with Positive EPS on Milestone Gain Stock Rises AllianceBernstein Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions CMSA Q1 2026 Earnings EPS Beats Estimates Amid Stable Utility Operations VOYA Q1 2026 Earnings EPS Surpasses Estimates by 8 Amid Solid Underwriting and Fee Income